Cite
HARVARD Citation
Hirsch, I. et al. (2017). Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal–bolus treatment in people with Type 1 diabetes: 1–year results from a randomized clinical trial (BOOST® T1). Diabetic medicine. 34 (2), pp. 167-173. [Online].